Document Detail

Safety of ginger use in pregnancy: results from a large population-based cohort study.
MedLine Citation:
PMID:  22706624     Owner:  NLM     Status:  Publisher    
PURPOSE: The objective of the study was to examine the safety of ginger use during pregnancy on congenital malformations and selected pregnancy outcomes. METHODS: The Norwegian Mother and Child Cohort study, a large population-based cohort, provided the data used in this study. Our study population consisted of 68,522 women. Data on ginger use and socio-demographic factors were retrieved from three self-administered questionnaires completed by the women during weeks 17 and 30 of the pregnancy and when their child was 6 months old. Data on pregnancy outcomes were provided by the Medical Birth Registry of Norway. RESULTS: Among the 68,522 women in the study, 1,020 (1.5 %) women reported using ginger during pregnancy. The use of ginger during pregnancy was not associated with any increased risk of congenital malformations. No increased risk for stillbirth/perinatal death, preterm birth, low birth weight, or low Apgar score was detected for the women exposed to ginger during pregnancy compared to women who had not been exposed. CONCLUSION: Use of ginger during pregnancy does not seem to increase the risk of congenital malformations, stillbirth/perinatal death, preterm birth, low birth weight, or low Apgar score. This finding is clinically important for health care professionals giving advice to pregnant women with NPV.
Kristine Heitmann; Hedvig Nordeng; Lone Holst
Related Documents :
22919524 - Placental mesenchymal dysplasia: a case report.
22902204 - Novel human polyomaviruses in pregnancy: higher prevalence of bkpyv, but no wupyv, kipy...
633214 - Pregnancy in the domestic cat after artificial insemination with previously frozen sper...
6831274 - Time relationships between oviposition, ovulation and egg formation in khaki campbell d...
11855154 - Dyspnea and palpitation during pregnancy.
22930024 - Maternal obesity in high-risk pregnancies and postpartum infectious complications.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-17
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  -     ISSN:  1432-1041     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-6-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Public Health and Primary Health Care and Centre of Pharmacy, University of Bergen, P.O. Box 7804, 5020, Bergen, Norway,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacr...
Next Document:  Development of a specially tailored local drug delivery system for the prevention of fibrosis after ...